=Oxford Immunotec (OXFD) reported earnings on Mon 11 March 19 (a/h)

Oxford Immunotec reports Q4 results, beats on revs; guides FY19 revs in-line

• Reports Q4 (Dec) earnings of $1.25 per share, may not compare to the S&P Capital IQ Consensus of ($0.19); revenues rose 22.2% year/year to $15.4 mln vs the $15.18 mln S&P Capital IQ Consensus.
• Adjusted EBITDA was a loss of $1.2 million for 4Q18 compared to a loss of $5.2 million in the same period in 2017.
• Co issues in-line guidance for FY19, sees FY19 revs of $69-$72 mln vs. $69.73 mln S&P Capital IQ Consensus.

Earnings this week : March 11 - 15, 2019 (wk 11)

Earnings confirmed for this week

Monday (March 11)

• Morning: None
• Afternoon: ADT COUP KRO OXFD  PETQ SFIX

Tuesday (March 12)

• Morning: DKS IPI KEYW MOMO NOG 
• Afternoon: APEI CLNE COHU EVRI GH QHC NTRA  SENS SNCR SWCH  TEUM ZAGG ZTO  

Wednesday (March 13)

• Morning: DQ EXPR  LXRX  SGRY VRA
• Afternoon: APYX CLDR DOMO FSM GDS KINS MDB NNBR SFS SMTC TLRD

Thursday (March 14)

• Morning: BIOS CNNE DG ERJ GCO HUD INAP LX PPDF RDNT SND TEN UXIN
• Afternoon:  ADBE ASNA AVGO AVID DOCU HEAR HTHT JBL MRAM NDLS ORCL PVTL TERP TLYS TRQ TUSK ULTA VRAY WSC ZUMZ

Friday (March 15)

• Morning: BIOS BKE CTRN DPLO KIRK MDCA